Published: Sep 21, 2021
Pfizer and German biotechnology firm BioNTech SE on Tuesday released results from a Phase 2/3 trial showing a favourable safety profile and robust neutralising antibody responses in children aged five to 11 using a two-dose regimen of 10µg (microgram) administered 21 days apart. This dose is smaller than the 30µg used for children above 12.
Published: Jul 05, 2021
Some senior doctors are worried that the arrival of the mRNA Pfizer vaccine will make recipients of the Sinovac vaccine believe they have been given an inferior product, Public Health Minister Anutin Charnvirakul said on Monday.
Published: Jul 04, 2021
The Covid-19 situation has aggravated since April due to the mutations of the virus, and the spreading of the Delta variant, Dr Sophon Iamsirithavorn, deputy director-general of the Department of Disease Control said.